News from samsung biologics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 27, 2022, 02:42 ET Samsung Biologics Reports First Quarter 2022 Financial Results

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, today announced strong financial results ...

Apr 20, 2022, 02:45 ET Samsung Biologics completes full acquisition of Samsung Bioepis

Samsung Biologics (KRX: 207940.KS) announced today that it has completed the purchase of Biogen's stake in the Samsung Bioepis joint venture for USD...

Mar 28, 2022, 21:42 ET Samsung Biologics holds 11th Annual General Meeting of Shareholders

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization (CDMO), hosted its 11th Annual General...

Feb 07, 2022, 07:00 ET Samsung Biologics receives 2022 CMO Leadership Award in all six categories

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization (CDMO), announced that it has been...

Jan 27, 2022, 19:10 ET Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis

Samsung Biologics (KRX: 207940.KS) announced today that it has reached an agreement with Biogen for the buyout of Biogen's stake in the Samsung...

Jan 24, 2022, 03:25 ET Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, today announced strong financial results ...

Jan 12, 2022, 19:52 ET Samsung Biologics Shares Strategic Roadmap for Sustainable Growth at the 40th Annual JP Morgan Healthcare Conference

Samsung Biologics (KRX: 207940.KS) announced its sustainable growth plan for this year at the 2022 Annual JP Morgan Healthcare Conference, which is...

Dec 13, 2021, 19:55 ET Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy

Samsung Biologics (207940.KS), the world's leading contract development and manufacturing organization, continues its strategic biopharmaceutical...

Dec 07, 2021, 00:04 ET Samsung Biologics adds to global ISO certifications with Quality Management System

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, held an award ceremony with the British...

Nov 24, 2021, 07:00 ET GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing

GreenLight Biosciences (Nasdaq: ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for...

Oct 26, 2021, 03:23 ET Samsung Biologics Reports Third Quarter 2021 Financial Results

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced record-high financial...

Oct 07, 2021, 08:00 ET Enzolytics Inc. and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibody Therapies

Samsung Biologics (KRX: 207940. K.S.), a leading contract development and manufacturing organization and Enzolytics (ENZC), a drug development...

Sep 22, 2021, 06:00 ET Samsung Biologics showcases its newest CDO process platform, S-Cellerate™, at BPI 2021, offering expedited timeline to IND and BLA

Samsung Biologics, a global contract development and manufacturing organization (CDMO), introduced its proprietary technology platform,...

Sep 13, 2021, 00:41 ET Samsung Biologics Joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, announced the signing of an MOU today to ...

Jul 27, 2021, 03:49 ET Samsung Biologics Reports Second Quarter 2021 Financial Results

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, today announced strong financial results ...

Jul 20, 2021, 08:00 ET Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy

Samsung Biologics (KRX: 207940.KS), one of the world's leading contract development and manufacturing organization (CDMO), signed a strategic...

Jun 24, 2021, 21:01 ET Samsung Biologics Issues Its First Annual Sustainability Report

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization (CDMO), published its first annual...

Jun 23, 2021, 07:28 ET Over a year into the global pandemic, Samsung Biologics continues to leverage innovative virtual platform for remote audits and regulatory inspections

Samsung Biologics, a global contract development and manufacturing organization (CMDO), celebrated the one-year mark of Live Virtual Tour (LVT), a...

Jun 02, 2021, 07:00 ET Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, signed a strategic partnership with KAHR ...

May 31, 2021, 07:00 ET Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services

Samsung Biologics (KRX: 207940.KS), a leading global CDMO providing end-to-end contract development and manufacturing services, today announced its...

May 28, 2021, 08:00 ET Samsung Biologics Adds Four Global ISO Certifications For BCMS, Energy, Health & Safety, and Environmental Management

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, announced today that the company has...

May 22, 2021, 12:00 ET Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine

Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Samsung Biologics (KRX: 207940.KS), a...

Apr 28, 2021, 04:37 ET Samsung Biologics Reports First Quarter 2021 Financial Results

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, today announced financial results for...

Apr 25, 2021, 19:10 ET Samsung Biologics and TG Therapeutics Expand Collaboration for the Large Scale Manufacture of Ublituximab

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization and TG Therapeutics (NASDAQ: TGTX), today ...

Apr 21, 2021, 07:00 ET Samsung Biologics Celebrates Its 10th Anniversary with Its Mission, "Driven. For Life."

Samsung Biologics, the world's leading contract development and manufacturing organization, celebrated the 10th anniversary of its founding today at...